Follow-up (mo) since sRARP, median (IQR) | 22 (16–32) |
Postoperative RT, n (%) | 0 |
Metastasis, n (%) | 0 |
Continence, n (%) | |
Pad free after 3 months | 14 |
Pad free after 6 months | 1 |
Incontinent | 0 |
Erections, n (%) | |
Potent | 5 (33%) |
Potent with PDE-5 inhibitor | 4 (27%) |
Impotent | 6 (40%) |